An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia

Maria Nobile, Barbara Bellotti, Cecilia Marino, Massimo Molteni, Marco Battaglia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and the Clinical Global Impression Improvement Scale (CGI-I). Seventy-one percent of patients had a satisfactory response, suggesting the efficacy of paroxetine in children with dysthymia.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalJournal of Child and Adolescent Psychopharmacology
Volume10
Issue number2
Publication statusPublished - Jun 2000

Fingerprint

Paroxetine
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia. / Nobile, Maria; Bellotti, Barbara; Marino, Cecilia; Molteni, Massimo; Battaglia, Marco.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 10, No. 2, 06.2000, p. 103-109.

Research output: Contribution to journalArticle

@article{909a418f721540448c14db89d5e0f562,
title = "An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia",
abstract = "This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and the Clinical Global Impression Improvement Scale (CGI-I). Seventy-one percent of patients had a satisfactory response, suggesting the efficacy of paroxetine in children with dysthymia.",
author = "Maria Nobile and Barbara Bellotti and Cecilia Marino and Massimo Molteni and Marco Battaglia",
year = "2000",
month = "6",
language = "English",
volume = "10",
pages = "103--109",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia

AU - Nobile, Maria

AU - Bellotti, Barbara

AU - Marino, Cecilia

AU - Molteni, Massimo

AU - Battaglia, Marco

PY - 2000/6

Y1 - 2000/6

N2 - This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and the Clinical Global Impression Improvement Scale (CGI-I). Seventy-one percent of patients had a satisfactory response, suggesting the efficacy of paroxetine in children with dysthymia.

AB - This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and the Clinical Global Impression Improvement Scale (CGI-I). Seventy-one percent of patients had a satisfactory response, suggesting the efficacy of paroxetine in children with dysthymia.

UR - http://www.scopus.com/inward/record.url?scp=0033914260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033914260&partnerID=8YFLogxK

M3 - Article

C2 - 10933120

AN - SCOPUS:0033914260

VL - 10

SP - 103

EP - 109

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 2

ER -